How direct technology ownership strengthens governance, security, innovation, and long-term continuity in national pharmaceutical traceability.
Traceability in the Pharma Industry
This section highlights the critical role of traceability in pharmaceuticals, where patient safety and regulatory compliance are non-negotiable. From serialization to Pharmaceutical track and trace, traceability ensures medicines are authentic, safe, and accessible. Read More
Beyond Drug Theft: Why Traceability Is Becoming Critical for High-Risk Medications
How digital traceability helps healthcare organizations move beyond physical security to improve visibility, prevent diversion, and safeguard controlled substances.
Pharmaceutical Supply Chain: Critical Challenges and Standards for the Global Healthcare Sector
The pharmaceutical supply chain relies on end-to-end traceability, international standards, and resilient collaboration to ensure patient safety, regulatory compliance, and product integrity across global healthcare networks.
Addressing Pharmaceutical Threats: Why Serialization and Traceability Are Critical to National Health and Security
How track & trace systems help prevent counterfeit medicines, strengthen regulatory oversight, and protect public health through end-to-end pharmaceutical supply chain visibility.
DSCSA Compliance in Practice: Managing Interoperable Traceability
A practical guide to DSCSA interoperability, EPCIS data exchange, partner readiness, and real-world traceability execution.
Italy and EU-FMD: From the Bollino System to EU-Wide Serialization
Italy is moving from its legacy Bollino system to the EU-FMD framework. Here’s what pharmaceutical companies need to know about serialization, packaging changes, system integration, and operational readiness ahead of the 2027 go-live.
Time Out of Refrigeration (TOR): A Critical Challenge in the Era of RNA and Biologic Therapies
How to manage TOR in the pharmaceutical supply chain to protect product stability, patient safety, and regulatory compliance.
Why the DSCSA Playbook Won’t Work for the FDA NDC12 Transition
The FDA’s move to a uniform 12-digit NDC isn’t a DSCSA-style compliance rollout—it’s an enterprise data and systems integration overhaul.
Key Considerations for Government Officials Regarding Unproven Traceability Providers
How public authorities can assess traceability vendors, ensure standards compliance, and protect national drug supply chains.
NDC12 FDA Rule: Drug Identification & Supply Chain Impact
A structural shift in drug identification, reshaping pharmaceutical traceability, compliance frameworks, and supply chain data systems.
GCC Regulatory Affairs Summit 2026: Compliance & Digital Transformation
Key insights on eCTD, SFDA and MOHAP regulations, pharmacovigilance, serialization, and GCC track-and-trace shaping the future of pharmaceutical compliance.
How Digital Leaflets Meet EU 2026 Compliance Requirements
A regulatory roadmap for ePI, FMD serialization, and EU digital pharmaceutical compliance.
FDA’s 12-Digit NDC Format: Essential Guide for Drug Supply Chain Teams
How the FDA’s transition to a standardized 12-digit National Drug Code (NDC) format is reshaping pharmaceutical labeling, traceability, and compliance across the U.S. drug supply chain.
Designing National Traceability Systems with Manufacturers at the Core: The Pharma Industry Case
Designing National Traceability Systems with manufacturers at the core: the pharma industry case.
Pharma Track & Trace: Serialization, AI & Blockchain in $28.6B Market
Serialization AI and blockchain driving innovation and compliance in the growing pharma traceability market.
What You’ll Find Here
Here you’ll find content that explains how pharmaceutical companies implement traceability systems to fight pharma counterfeiting, improve product recalls, and meet global regulations. Articles also explore how digital tools streamline supply chains and hospital logistics.
In this section, you will find:
- Articles on serialization and track & trace systems.
- Insights into Unique Device Identification (UDI) and medical compliance.
- Analyses of global regulations (EU FMD, US DSCSA, WHO guidance).
- Guides on how traceability supports patient safety, quality, and efficiency.
Browse the most recent Pharma traceability articles. This section updates automatically as new content is published.
